12.23.25 -- 2025's Top 5 Drug Discovery Highlights And How To Stay Ahead In 2026

From AI to adaptive trial designs, the industry is undergoing a transformation that is equal parts scientific breakthrough and strategic recalibration. Learn what innovations are poised to redefine pipelines.

Hear from Dr. Fabio Luciani, Professor and Senior Researcher in Systems Immunology at the School of Medical Sciences and the Kirby Institute at UNSW Sydney about his recent research.

Review the role of solid form screening and PBPK modeling to enable accelerated timelines desirable in early-phase drug development. Explore formulation maps for ASDs and key criteria for salt screening.

Discover how mammalian display enhances T cell receptor-based cancer therapies. This method improves antigen affinity and reduces immunogenicity for more effective treatments.

See a new biophysical method that simplifies PROTAC characterization, improves assay development, and delivers high-quality affinity data even for complex interactions.

Watch as experts walk through several technologies and case studies, focusing on liquid-phase peptide synthesis, crystallization, method development for impurity analysis, and more.

Creating a greener manufacturing platform that accommodates solvent recovery and recycling requires careful consideration of your resources, procedures, and partnerships to achieve cost-effective goals.

Uncover the application of a platform in creating CHO cell lines for manufacturing multi-chain biologics, emphasizing the uniformity of the pools generated by this platform and the rapid selection of them.